COMPARISON OF EFFICACY OF TOPICAL ADAPALENE PLUS ORAL AZITHROMYCIN AND TOPICAL ADAPALENE PLUS ORAL DOXYCYCLINE IN TREATMENT OF ACNE VULGARIS

Authors

  • Ghafoor Ullah Dermatology Unit, Hayatabad Medical Complex Peshawar Pakistan
  • Farhad Ali
  • Mohammad Majid Paracha
  • Sahibzada Mehmood Noor
  • Jawad Naeem

DOI:

https://doi.org/10.55519/JAMC-04-9568

Keywords:

Azithromycin, Doxycycline, Adapalene , Acne vulgaris

Abstract

Background: Acne vulgaris is a commonly diagnosed dermatological condition characterised by pilosebaceous unit blockage or inflammation. It may manifest as inflammatory, non-inflammatory, or a combination of the two. The acne vulgaris mostly the face of indvivdual and chest and back of individual is also affected sometime. the aim of my research is to compare the effectiveness of topical adapalene plus oral azithromycin versus topical adapalene plus oral doxycycline in treating acne. Acne is one of most common reason compelling a patient to see dermatological advice. Our goal is to find the most effective antibiotic to produce the best outcomes with the fewest possible unwanted effect (side effects) and a maximum level of patient satisfaction. Methods: From May 1 to October 31, 2019, a randomised control trial was performed at Dermatology department MTI Lady Reading Hospital Peshawar. Using the lottery form, all of the patients were split into 2 groups. For 12 weeks, patients in Group A were given oral doxycycline 100 mg once daily and topical adapalene, while patients in Group B were given oral azithromycin 250 mg on alternating days and topical adapalene. All patientswere followed at the end of 12 weeks after start of therapy to determine the efficacy in term of clearance of at least 60% of the number of lesions from baseline. Results: In Group A, 22 (59.45%) patients expressed positive results whereas in Group B, only 9 (24.32%) patients expressed positive results.  p-value (0.0021.) Conlcusion: My data suggest that oral doxycycline 100mg in combination with adapalene gave better results as compared to oral azithromycin which was also found well-tolerated option for treatment of acne on face.

Author Biography

Ghafoor Ullah, Dermatology Unit, Hayatabad Medical Complex Peshawar Pakistan

Assistant Professor

References

Al-Hammadi A, Al-Ismaily A, Al-Ali S, Ramadurai R, Jain R, Grant LM, et al. Topical, biological and clinical challenges in the management of patients with acne vulgaris. Sultan Qaboos Uni Med J. 2016;6(2):e152-e160.

Omer H, McDowell A, Alexeyev OA. Understanding the role of Propionibacterium acnes in acne vulgaris: The critical importance of skin sampling methodologies. Clin Dermatol. 2017;35(2):118-29.

Park C, Kim G, Patel I, Chang J, Tan X. Improving adherence to acne treatment: the emerging role of application software. Clin Cosmet Investig Dermatol. 2014;7:65-72.

Al-Shobaili HA. Knowledge and practice of primary healthcare physicians for management of acne vulgaris in Qassim region, Saudi Arabia. J Egypt Public Health Assoc. 2013;88(1):26-31.

Kim SY, Ochsendorf FR. New developments in acne treatment: role of combination adapalene-benzoylperoxide. Ther Clin Risk Manag. 2016;12:1497-506.

Kim SY, Ochsendorf FR. Topical and oral antibiotics for acne vulgaris. Semin Cutan Med Surg. 2016;35(2):57-61.

Sao Paulo. Evidence on acne therapy Med J. 2013;131(3):193-7.

Rassai S, Rafeie E, Ramirez-Fort MK, Feily A, Adjuvant narrow band uvb improves the efficacy of oral azithromycin for the treatment of moderate to severe inflammatory facial acne vulgaris. J Cutan Aesthet Surg. 2014;7(3):151-54.

Farrah G, Tan E. The use of oral antibiotics in treating acne vulgaris: a new approach. Dermatol Ther. 2016 Sep;29(5):377-84.

Ullah G, Noor SM, Bhatti Z, Ahmed M, Bangash AR. Comparison of oral azithromycin with oral doxycycline in the treatment of acne vulgaris. J Ayub med coll Abbottabad 2014:26(1):64-7.

Akman A., Durusoy C., Senturk M., Koc C.K., Soyturk D., Alpsoy E. Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study. Arch Dermatol Res. 2007;299(10):467-473.

Antonio J.R., Pegas J.R., Cestari T.F., Do Nascimento L.V. Azithromycin pulses in the treatment of inflammatory and pustular acne: efficacy, tolerability and safety. J Dermatolog Treat. 2008;19(4):210-215.

Babaeinejad S., Khodaeiani E., Fouladi R.F. Comparison of therapeutic effects of oral doxycycline and azithromycin in patients with moderate acne vulgaris: What is the role of age? J Dermatolog Treat. 2011;22(4):206-210.

Bojar R.A., Eady E.A., Jones C.E., Cunliffe W.J., Holland K.T. Inhibition of erythromycin-resistant propionibacteria on the skin of acne patients by topical erythromycin with and without zinc. Br J Dermatol. 1994;130(3):329-336.

Bradford L.G., Montes L.F. Topical application of vitamin A acid in acne vulgaris. South Med J. 1974;67(6):683-687.

Christiansen J.V., Gadborg E., Ludvigsen K., Meier C.H., Norholm A., Pedersen D. Topical tretinoin, vitamin A acid (Airol) in acne vulgaris. A controlled clinical trial. Dermatologica. 1974;148(2):82-89.

Cochran R.J., Tucker S.B., Flannigan S.A. Topical zinc therapy for acne vulgaris. Int J Dermatol. 1985;24(3):188-190.

Cunliffe W.J., Caputo R., Dreno B., Forstrom L., Heenen M., Orfanos C.E. Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and U.S. multicenter trials. J Am Acad Dermatol. 1997;36(6 Pt 2):S126-34.

De D., Kanwar A.J. Combination of low-dose isotretinoin and pulsed oral azithromycin in the management of moderate to severe acne: a preliminary open-label, prospective, non-comparative, single-centre study. Clin Drug Investig. 2011;31(8):599-604.

Draelos Z.D., Carter E., Maloney J.M., Elewski B., Poulin Y., Lynde C. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris. J Am Acad Dermatol. 2007;56(3):439-42.

Downloads

Published

2022-09-28

How to Cite

Ullah, G., Farhad Ali, Mohammad Majid Paracha, Sahibzada Mehmood Noor, & Jawad Naeem. (2022). COMPARISON OF EFFICACY OF TOPICAL ADAPALENE PLUS ORAL AZITHROMYCIN AND TOPICAL ADAPALENE PLUS ORAL DOXYCYCLINE IN TREATMENT OF ACNE VULGARIS. Journal of Ayub Medical College Abbottabad, 34(4), 786–789. https://doi.org/10.55519/JAMC-04-9568

Issue

Vol. 34 No. 4 (2022): JOURNAL OF AYUB MEDICAL COLLEGE ABBOTTABAD

Section

ORIGINAL ARTICLE

License

Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License  CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.

USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.

AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.